Canadian Cancer Trials Group Bulletins


Recent Publication

There was one recent publication related to Canadian Cancer Trials Group BR.21 - A Randomized Placebo Controlled Study of OSI-774 (Tarceva) in Patients with Incurable Stage IIIB/IV Non-Small Cell Lung Cancer Who Have Failed Standard Therapy for Advanced or Metastatic Disease.

Hilton JF, Tu D, Seymour L, Shepherd FA, Bradbury PA. An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib (ONLINE). Lung Cancer, July 31, 2013.